The approval of ArteraAI Prostate by the FDA as a software as a medical device (SaMD) means it can now be used at the point ...

The FDA’s De Novo authorization for the tool establishes a new product code category for future AI-powered digital pathology risk-stratification tools.

The US Food and Drug Administration (FDA) has granted de novo authorisation to Artera’s ArteraAI Prostate software. This ...

Key Points Spectral Ai completed its De Novo application submission to the FDA for the DeepView System in June 2025, marking a major regulatory milestone. Revenue for the quarter declined 32.0% year ...

Abridge is looking for acquisitions after raising $700 million in 18 months. Here's what the red-hot health AI startup wants ...

Q2 2025 Earnings Call Transcript August 13, 2025 Hyperfine, Inc. reports earnings inline with expectations. Reported EPS is $ ...

Artificial intelligence is transforming healthcare — we must align government policies to support this progress. It will save ...

Gained alignment with U.S. Food and Drug Administration (FDA) on the ongoing Phase 2 AQUAx2 randomized double-blind, placebo-controlled pivotal study in Grade 2/3 radiation-induced xerostomia (RIX) to ...

The American Psychological Association (APA) has called on the Federal Trade Commission to investigate “deceptive practices” ...

Oregon Health & Science University said a trained AI program can detect cancer of a larynx by picking up the distinct ...

In this week’s InnovationRx newsletter, we look at longevity drugs for dogs, programmable mRNA for fighting cancer, AI models ...

Slightly altering your stride while walking could considerably ease pain caused by wear-and-tear knee arthritis, New York ...